methylformamide has been researched along with Lung Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amedeo, C; Biroccio, A; Bucci, B; Del Bufalo, D; Falcioni, R; Leonetti, C; Zupi, G | 1 |
| Cody, RL; Natale, RB; Seid, JE | 1 |
| Abeloff, MD; Chang, YC; Ettinger, DS; Finkelstein, DM; Oken, MM; Ruckdeschel, JC; Smith, TJ | 1 |
| Blum, R; Chang, AY; Donehower, RC; Ettinger, DS; Finkelstein, DM; Green, M; Hahn, RG; Ruckdeschel, JC | 1 |
| Iwakawa, M; Milas, L; Tofilon, P | 1 |
| Dale, IL; Gescher, A; Lazenby, CM | 1 |
| Milas, L; Tofilon, PJ; Vines, CM | 1 |
| Hollander, P; Scher, HI; Sternberg, CN; Yagoda, A | 1 |
| Hunter, N; Iwakawa, M; Milas, L; Tofilon, PJ | 1 |
3 trial(s) available for methylformamide and Lung Neoplasms
| Article | Year |
|---|---|
Phase II trial of N-methylformamide in lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Formamides; Humans; Lung Neoplasms; Male; Middle Aged | 1992 |
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation; Female; Formamides; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Random Allocation; Spiro Compounds | 1990 |
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Formamides; Germanium; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Prognosis; Random Allocation; Remission Induction; Spiro Compounds | 1989 |
6 other study(ies) available for methylformamide and Lung Neoplasms
| Article | Year |
|---|---|
N-methylformamide induces changes on adhesive properties and lung-colonizing potential of M14 melanoma cells.
Topics: Animals; Cell Adhesion; Cell Adhesion Molecules; Extracellular Matrix Proteins; Fibrinogen; Formamides; Humans; Integrins; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Maturational agents alone or in combination with cytotoxic agents in therapy of tumor metastases.
Topics: Animals; Antineoplastic Agents; Female; Fibrosarcoma; Formamides; Liver Neoplasms, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Metastasis | 1988 |
Effect of two inducers of cellular differentiation on the glutathione status of human HL-60 promyelocytic leukaemia and A549 lung carcinoma cells.
Topics: Animals; Carcinoma; Cell Differentiation; Cell Line; Dimethyl Sulfoxide; Formamides; Glutathione; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Mice; Neoplasms, Experimental; Tetradecanoylphorbol Acetate | 1987 |
The effects of N-methylformamide on artificial and spontaneous metastases from a murine hepatocarcinoma.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Formamides; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Neoplasm Metastasis | 1987 |
Phase II trial of N-methylformamide for advanced renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Drug Evaluation; Female; Formamides; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea | 1986 |
Modification of tumor and normal tissue radioresponse in mice by N-methylformamide.
Topics: Animals; Combined Modality Therapy; Female; Formamides; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiation-Sensitizing Agents | 1987 |